In conclusion, our study demonstrated that targeting LEF1/Id3/HRAS axis may suppress ESCC cell growth, migration, invasion and EMT via blocking ERK/MAPK signaling pathway. The gene discussed is LEF1; the disease is esophageal squamous cell carcinoma.